More about High-Yield Cash Accounts with M1
Brokerage Accounts
Retirement Accounts
Other Accounts
Quotes are delayed by 15 minutes.
1D
1W
1M
3M
6M
YTD
1Y
2Y
5Y
ALL
Market cap
$227958347
EPS
-1.29
P/E ratio
--
Price to sales
1.7
Dividend yield
--
Beta
0.880488
Previous close
$0.55
Today's open
$0.55
Day's range
$0.53 - $0.56
52 week range
$0.53 - $2.38
show more
CEO
Luc Mongeau
Employees
1029
Headquarters
Smiths Falls, ON
Exchange
Nasdaq Global Select
Shares outstanding
423352668
Issue type
Common Stock
Healthcare
Pharmaceuticals
Cannabis Stock CGC Loses 26% in a Month: Should You Buy the Dip?
Canopy Growth's 26% monthly plunge follows disappointing earnings, but international cannabis growth and cost savings offer some positives.
Zacks Investment Research • an hour ago

Investors Heavily Search Canopy Growth Corporation (CGC): Here is What You Need to Know
Zacks.com users have recently been watching Canopy Growth (CGC) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Zacks Investment Research • Nov 12, 2026

Canopy Growth Corporation: 3 Key Takeaways for Long-Term Investors
International cannabis net revenue grew 141% year over year to $12.3 million. Cultivation yields have the potential to increase 25% to 30% in the Kincardine facility.
The Motley Fool • Nov 7, 2026

Canopy Growth Q2 Earnings Call Highlights
Canopy Growth NASDAQ: CGC reported a 22% increase in fiscal second-quarter revenue as international cannabis sales more than doubled, and executives said the company remains on track to achieve positive adjusted EBITDA in the second half of fiscal 2027.
MarketBeat • Nov 6, 2026

Canopy Growth Corporation (WEED:CA) Q2 2027 Earnings Call Transcript
Canopy Growth Corporation ( WEED:CA ) Q2 2027 Earnings Call November 6, 2026 10:00 AM EST Company Participants John Vincic Luc Mongeau - CEO & Director Thomas Stewart - Chief Accounting Officer & CFO Conference Call Participants Aaron Grey - Alliance Global Partners, Research Division William Kirk - ROTH Capital Partners, LLC, Research Division Kenric Tyghe - Canaccord Genuity Corp., Research Division Frederico Yokota Gomes - ATB Cormark Capital Markets Inc., Research Division Pablo Zuanic - Zuanic & Associates Presentation Operator Good morning. My name is Joanna, and I will be your conference operator today.
Seeking Alpha • Nov 6, 2026

Canopy Growth Reports Second Quarter Fiscal Year 2027 Financial Results; Net Revenue Growth of 22% Led by a 141% Increase in International Markets Cannabis
SMITHS FALLS, Ontario--(BUSINESS WIRE)--Canopy Growth Corporation (“Canopy Growth”, “our”, “we” or the “Company”) (TSX: WEED) (Nasdaq: CGC), a leading global company committed to bettering lives through cannabis, today announced its financial results for the three months ended September 30, 2026 ("Q2 FY2027"). All financial information in this press release is reported in Canadian dollars, unless otherwise indicated. “We have made tremendous progress on our international strategy. Our internati.
Business Wire • Nov 6, 2026

Canopy Growth Corporation (CGC) Reports Q2 Loss, Lags Revenue Estimates
Canopy Growth Corporation (CGC) came out with a quarterly loss of $0.07 per share versus the Zacks Consensus Estimate of a loss of $0.02. This compares to a loss of $0.01 per share a year ago.
Zacks Investment Research • Nov 6, 2026

Canopy Growth vs. Tilray Brands: Quarterly Revenue Scale and Consistency in Cannabis
Canopy Growth (CGC -4.34%) primarily generates revenue by selling medical and recreational cannabis products to consumers across several international regions.
The Motley Fool • Oct 30, 2026

Canopy Growth Corporation (CGC) is Attracting Investor Attention: Here is What You Should Know
Canopy Growth (CGC) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Zacks Investment Research • Oct 29, 2026

Canopy Growth Corporation (CGC) Beats Stock Market Upswing: What Investors Need to Know
Canopy Growth Corporation (CGC) closed the most recent trading day at $0.68, moving +2.42% from the previous trading session.
Zacks Investment Research • Oct 27, 2026

¹ Disclosures

Open an M1 investment account to buy and sell Canopy Growth Corporation commission-free¹. Build wealth for the long term using automated trading and transfers.